United States Recombinant Protein Drugs Industry 2016 Market Research Report
The United States Recombinant Protein Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Recombinant Protein Drugs industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Protein Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Protein Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Protein Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Protein Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW
1.1 Definition and Specifications of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
1.3 Applications of Recombinant Protein Drugs
1.4 Industry Chain Structure of Recombinant Protein Drugs
1.5 Industry Overview of Recombinant Protein Drugs
1.6 Industry Policy Analysis of Recombinant Protein Drugs
1.7 Industry News Analysis of Recombinant Protein Drugs
2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT PROTEIN DRUGS
2.1 Bill of Materials (BOM) of Recombinant Protein Drugs
2.2 BOM Price Analysis of Recombinant Protein Drugs
2.3 Labor Cost Analysis of Recombinant Protein Drugs
2.4 Depreciation Cost Analysis of Recombinant Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
2.6 Manufacturing Process Analysis of Recombinant Protein Drugs
2.7 United States Price, Cost and Gross of Recombinant Protein Drugs 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Recombinant Protein Drugs Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Recombinant Protein Drugs Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Recombinant Protein Drugs Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF RECOMBINANT PROTEIN DRUGS BY REGIONS, TYPE, AND APPLICATIONS
4.1 United States Production of Recombinant Protein Drugs by Regions 2011-2016
4.2 United States Production of Recombinant Protein Drugs by Type 2011-2016
4.3 United States Sales of Recombinant Protein Drugs by Applications 2011-2016
4.4 Price Analysis of United States Recombinant Protein Drugs Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant Protein Drugs 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF RECOMBINANT PROTEIN DRUGS BY REGIONS
5.1 United States Consumption Volume of Recombinant Protein Drugs by Regions 2011-2016
5.2 United States Consumption Value of Recombinant Protein Drugs by Regions 2011-2016
5.3 United States Consumption Price Analysis of Recombinant Protein Drugs by Regions 2011-2016
6 ANALYSIS OF RECOMBINANT PROTEIN DRUGS PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Recombinant Protein Drugs 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Recombinant Protein Drugs 2014-2015
6.3 Sales Overview of Recombinant Protein Drugs 2011-2016
6.4 Supply, Consumption and Gap of Recombinant Protein Drugs 2011-2016
6.5 Import, Export and Consumption of Recombinant Protein Drugs 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Recombinant Protein Drugs 2011-2016
7 ANALYSIS OF RECOMBINANT PROTEIN DRUGS INDUSTRY KEY MANUFACTURERS
7.1 Novo Nordisk
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Novo Nordisk SWOT Analysis
7.2 Amgen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Amgen SWOT Analysis
7.3 Sanofi
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Sanofi SWOT Analysis
7.4 Eli Lilly
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Eli Lilly SWOT Analysis
7.5 Merck Serono
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Merck Serono SWOT Analysis
7.6 Ortho Biotech
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Ortho Biotech SWOT Analysis
7.7 Roche
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Roche SWOT Analysis
7.8 Kyowa Hakko Kirin
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Kyowa Hakko Kirin SWOT Analysis
7.9 Pharmingen
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Pharmingen SWOT Analysis
7.10 Abcam
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Abcam SWOT Analysis
7.11 GenSci
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 GenSci SWOT Analysis
7.12 SL PHARM
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 SL PHARM SWOT Analysis
7.13 Dongbao Pharm
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Dongbao Pharm SWOT Analysis
7.14 Ankebio
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Ankebio SWOT Analysis
7.15 NCPC
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 NCPC SWOT Analysis
7.16 Heng Rui
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Heng Rui SWOT Analysis
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Recombinant Protein Drugs Product Types
8.5 Market Share Analysis of Different Recombinant Protein Drugs Price Levels
8.6 Gross Margin Analysis of Different Recombinant Protein Drugs Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF RECOMBINANT PROTEIN DRUGS
9.1 Marketing Channels Status of Recombinant Protein Drugs
9.2 Traders or Distributors of Recombinant Protein Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant Protein Drugs
9.4 United States Import, Export and Trade Analysis of Recombinant Protein Drugs
10 DEVELOPMENT TREND OF RECOMBINANT PROTEIN DRUGS INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Recombinant Protein Drugs 2016-2021
10.2 Production Market Share by Product Types of Recombinant Protein Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Recombinant Protein Drugs 2016-2021
10.4 United States Sales of Recombinant Protein Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Recombinant Protein Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Recombinant Protein Drugs 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF RECOMBINANT PROTEIN DRUGS WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Recombinant Protein Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Recombinant Protein Drugs with Contact Information
11.3 Major Players of Recombinant Protein Drugs with Contact Information
11.4 Key Consumers of Recombinant Protein Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Recombinant Protein Drugs
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF RECOMBINANT PROTEIN DRUGS
12.1 New Project SWOT Analysis of Recombinant Protein Drugs
12.2 New Project Investment Feasibility Analysis of Recombinant Protein Drugs
13 CONCLUSION OF THE UNITED STATES RECOMBINANT PROTEIN DRUGS INDUSTRY 2016 MARKET RESEARCH REPORT
1.1 Definition and Specifications of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
1.3 Applications of Recombinant Protein Drugs
1.4 Industry Chain Structure of Recombinant Protein Drugs
1.5 Industry Overview of Recombinant Protein Drugs
1.6 Industry Policy Analysis of Recombinant Protein Drugs
1.7 Industry News Analysis of Recombinant Protein Drugs
2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT PROTEIN DRUGS
2.1 Bill of Materials (BOM) of Recombinant Protein Drugs
2.2 BOM Price Analysis of Recombinant Protein Drugs
2.3 Labor Cost Analysis of Recombinant Protein Drugs
2.4 Depreciation Cost Analysis of Recombinant Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
2.6 Manufacturing Process Analysis of Recombinant Protein Drugs
2.7 United States Price, Cost and Gross of Recombinant Protein Drugs 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Recombinant Protein Drugs Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Recombinant Protein Drugs Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Recombinant Protein Drugs Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF RECOMBINANT PROTEIN DRUGS BY REGIONS, TYPE, AND APPLICATIONS
4.1 United States Production of Recombinant Protein Drugs by Regions 2011-2016
4.2 United States Production of Recombinant Protein Drugs by Type 2011-2016
4.3 United States Sales of Recombinant Protein Drugs by Applications 2011-2016
4.4 Price Analysis of United States Recombinant Protein Drugs Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant Protein Drugs 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF RECOMBINANT PROTEIN DRUGS BY REGIONS
5.1 United States Consumption Volume of Recombinant Protein Drugs by Regions 2011-2016
5.2 United States Consumption Value of Recombinant Protein Drugs by Regions 2011-2016
5.3 United States Consumption Price Analysis of Recombinant Protein Drugs by Regions 2011-2016
6 ANALYSIS OF RECOMBINANT PROTEIN DRUGS PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Recombinant Protein Drugs 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Recombinant Protein Drugs 2014-2015
6.3 Sales Overview of Recombinant Protein Drugs 2011-2016
6.4 Supply, Consumption and Gap of Recombinant Protein Drugs 2011-2016
6.5 Import, Export and Consumption of Recombinant Protein Drugs 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Recombinant Protein Drugs 2011-2016
7 ANALYSIS OF RECOMBINANT PROTEIN DRUGS INDUSTRY KEY MANUFACTURERS
7.1 Novo Nordisk
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Novo Nordisk SWOT Analysis
7.2 Amgen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Amgen SWOT Analysis
7.3 Sanofi
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Sanofi SWOT Analysis
7.4 Eli Lilly
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Eli Lilly SWOT Analysis
7.5 Merck Serono
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Merck Serono SWOT Analysis
7.6 Ortho Biotech
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Ortho Biotech SWOT Analysis
7.7 Roche
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Roche SWOT Analysis
7.8 Kyowa Hakko Kirin
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Kyowa Hakko Kirin SWOT Analysis
7.9 Pharmingen
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Pharmingen SWOT Analysis
7.10 Abcam
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Abcam SWOT Analysis
7.11 GenSci
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 GenSci SWOT Analysis
7.12 SL PHARM
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 SL PHARM SWOT Analysis
7.13 Dongbao Pharm
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Dongbao Pharm SWOT Analysis
7.14 Ankebio
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Ankebio SWOT Analysis
7.15 NCPC
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 NCPC SWOT Analysis
7.16 Heng Rui
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Heng Rui SWOT Analysis
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Recombinant Protein Drugs Product Types
8.5 Market Share Analysis of Different Recombinant Protein Drugs Price Levels
8.6 Gross Margin Analysis of Different Recombinant Protein Drugs Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF RECOMBINANT PROTEIN DRUGS
9.1 Marketing Channels Status of Recombinant Protein Drugs
9.2 Traders or Distributors of Recombinant Protein Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant Protein Drugs
9.4 United States Import, Export and Trade Analysis of Recombinant Protein Drugs
10 DEVELOPMENT TREND OF RECOMBINANT PROTEIN DRUGS INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Recombinant Protein Drugs 2016-2021
10.2 Production Market Share by Product Types of Recombinant Protein Drugs 2016-2021
10.3 Sales and Sales Revenue Overview of Recombinant Protein Drugs 2016-2021
10.4 United States Sales of Recombinant Protein Drugs by Applications 2016-2021
10.5 Import, Export and Consumption of Recombinant Protein Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Recombinant Protein Drugs 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF RECOMBINANT PROTEIN DRUGS WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Recombinant Protein Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Recombinant Protein Drugs with Contact Information
11.3 Major Players of Recombinant Protein Drugs with Contact Information
11.4 Key Consumers of Recombinant Protein Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Recombinant Protein Drugs
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF RECOMBINANT PROTEIN DRUGS
12.1 New Project SWOT Analysis of Recombinant Protein Drugs
12.2 New Project Investment Feasibility Analysis of Recombinant Protein Drugs
13 CONCLUSION OF THE UNITED STATES RECOMBINANT PROTEIN DRUGS INDUSTRY 2016 MARKET RESEARCH REPORT
LIST OF TABLES AND FIGURES
Figure Picture of Recombinant Protein Drugs
Table Product Specifications of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Product Types in 2015
Table Applications of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Applications in 2015
Figure Industry Chain Structure of Recombinant Protein Drugs
Table United States Industry Overview of Recombinant Protein Drugs
Table Industry Policy of Recombinant Protein Drugs
Table Industry News List of Recombinant Protein Drugs
Table Bill of Materials (BOM) of Recombinant Protein Drugs
Table Bill of Materials (BOM) Price of Recombinant Protein Drugs
Table Labor Cost of Recombinant Protein Drugs
Table Depreciation Cost of Recombinant Protein Drugs
Table Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2015
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Table United States Price Analysis of Recombinant Protein Drugs 2011-2016 (USD/MT)
Table United States Cost Analysis of Recombinant Protein Drugs 2011-2016 (USD/MT)
Table United States Gross Analysis of Recombinant Protein Drugs 2011-2016
Table Capacity (K MT) and Commercial Production Date of United States Recombinant Protein Drugs Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Recombinant Protein Drugs Manufacturers in 2015
Table R&D Status and Technology Source of United States Recombinant Protein Drugs Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Recombinant Protein Drugs Key Manufacturers in 2015
Table United States Production of Recombinant Protein Drugs by Regions 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Regions in 2015
Table United States Production of Recombinant Protein Drugs by Types in 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Type in 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2015
Table United States Sales of Recombinant Protein Drugs by Applications 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Applications 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2015
Table Price Comparison of United States Recombinant Protein Drugs Key Manufacturers in 2015 (USD/MT)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Recombinant Protein Drugs 2011-2016
Table United States Consumption Volume of Recombinant Protein Drugs by Regions 2011-2016 (K MT)
Table United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions in 2015
Table United States Consumption Value of Recombinant Protein Drugs by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Consumption Value Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Consumption Value Market Share of Recombinant Protein Drugs by Regions in 2015
Table Consumption Price of Recombinant Protein Drugs by Regions 2011-2016 (USD/MT)
Table United States and Major Manufacturers Capacity of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Capacity Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Production Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Recombinant Protein Drugs 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Recombinant Protein Drugs 2011-2016
Figure United States Capacity Utilization Rate of Recombinant Protein Drugs 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Recombinant Protein Drugs 2011-2016
Figure United States Production Market Share of Major Recombinant Protein Drugs Manufacturers in 2014
Figure United States Production Market Share of Major Recombinant Protein Drugs Manufacturers in 2015
Figure United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers in 2014
Figure United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers in 2015
Figure United States Sales (K MT) and Growth Rate of Recombinant Protein Drugs 2011-2016
Table United States Supply, Consumption and Gap of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Import, Export and Consumption of Recombinant Protein Drugs 2011-2016 (K MT)
Table Price of United States Recombinant Protein Drugs Major Manufacturers 2011-2016 (USD/MT)
Table Gross Margin of United States Recombinant Protein Drugs Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Recombinant Protein Drugs 2011-2016 (M USD)
Table United States Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Recombinant Protein Drugs 2011-2016
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Novo Nordisk
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Novo Nordisk 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Novo Nordisk 2011-2016
Table Novo Nordisk Recombinant Protein Drugs SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Amgen
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Amgen 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Amgen 2011-2016
Table Amgen Recombinant Protein Drugs SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Sanofi
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Sanofi 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Sanofi 2011-2016
Table Sanofi Recombinant Protein Drugs SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Eli Lilly
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Eli Lilly 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Eli Lilly 2011-2016
Table Eli Lilly Recombinant Protein Drugs SWOT Analysis
Table Merck Serono Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Merck Serono
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Merck Serono 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Merck Serono 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Merck Serono 2011-2016
Table Merck Serono Recombinant Protein Drugs SWOT Analysis
Table Ortho Biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Ortho Biotech
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Ortho Biotech 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Ortho Biotech 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Ortho Biotech 2011-2016
Table Ortho Biotech Recombinant Protein Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Roche
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Roche 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Roche 2011-2016
Table Roche Recombinant Protein Drugs SWOT Analysis
Table Kyowa Hakko Kirin Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Kyowa Hakko Kirin
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Kyowa Hakko Kirin 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Kyowa Hakko Kirin 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Kyowa Hakko Kirin 2011-2016
Table Kyowa Hakko Kirin Recombinant Protein Drugs SWOT Analysis
Table Pharmingen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Pharmingen
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Pharmingen 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Pharmingen 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Pharmingen 2011-2016
Table Pharmingen Recombinant Protein Drugs SWOT Analysis
Table Abcam Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Abcam
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Abcam 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Abcam 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Abcam 2011-2016
Table Abcam Recombinant Protein Drugs SWOT Analysis
Table GenSci Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of GenSci
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of GenSci 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of GenSci 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of GenSci 2011-2016
Table GenSci Recombinant Protein Drugs SWOT Analysis
Table SL PHARM Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of SL PHARM
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of SL PHARM 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of SL PHARM 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of SL PHARM 2011-2016
Table SL PHARM Recombinant Protein Drugs SWOT Analysis
Table Dongbao Pharm Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Dongbao Pharm
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Dongbao Pharm 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Dongbao Pharm 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Dongbao Pharm 2011-2016
Table Dongbao Pharm Recombinant Protein Drugs SWOT Analysis
Table Ankebio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Ankebio
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Ankebio 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Ankebio 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Ankebio 2011-2016
Table Ankebio Recombinant Protein Drugs SWOT Analysis
Table NCPC Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of NCPC
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of NCPC 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of NCPC 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of NCPC 2011-2016
Table NCPC Recombinant Protein Drugs SWOT Analysis
Table Heng Rui Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Heng Rui
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Heng Rui 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Heng Rui 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Heng Rui 2011-2016
Table Heng Rui Recombinant Protein Drugs SWOT Analysis
Table Recombinant Protein Drugs Price by Regions 2011-2016
Table Recombinant Protein Drugs Price by Product Types 2011-2016
Table Recombinant Protein Drugs Price by Companies 2011-2016
Table Recombinant Protein Drugs Gross Margin by Companies 2011-2016
Table Price Comparison of Recombinant Protein Drugs by Regions 2011-2016 (USD/MT)
Table Price of Different Recombinant Protein Drugs Product Types (USD/MT)
Table Market Share of Different Recombinant Protein Drugs Price Level
Table Gross Margin of Different Recombinant Protein Drugs Applications
Table Marketing Channels Status of Recombinant Protein Drugs
Table Traders or Distributors of Recombinant Protein Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Recombinant Protein Drugs (USD/MT) in 2015
Table United States Import, Export, and Trade of Recombinant Protein Drugs (K MT)
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Capacity Utilization Rate of Recombinant Protein Drugs 2016-2021
Table United States Recombinant Protein Drugs Production by Type 2016-2021 (K MT)
Table United States Recombinant Protein Drugs Production Market Share by Type 2016-2021
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2021
Figure United States Sales (K MT) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Sales of Recombinant Protein Drugs by Applications 2016-2021 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Applications 2016-2021
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2021
Table United States Production, Import, Export and Consumption of Recombinant Protein Drugs 2016-2021 (K MT)
Table United States Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Recombinant Protein Drugs 2016-2021
Table Major Raw Materials Suppliers of Recombinant Protein Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Recombinant Protein Drugs with Contact Information
Table Major Players of Recombinant Protein Drugs with Contact Information
Table Key Consumers of Recombinant Protein Drugs with Contact Information
Table Supply Chain Relationship Analysis of Recombinant Protein Drugs
Table New Project SWOT Analysis of Recombinant Protein Drugs
Table New Project Investment Feasibility Analysis of Recombinant Protein Drugs
Table Part of Interviewees Record List
Figure Picture of Recombinant Protein Drugs
Table Product Specifications of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Product Types in 2015
Table Applications of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Applications in 2015
Figure Industry Chain Structure of Recombinant Protein Drugs
Table United States Industry Overview of Recombinant Protein Drugs
Table Industry Policy of Recombinant Protein Drugs
Table Industry News List of Recombinant Protein Drugs
Table Bill of Materials (BOM) of Recombinant Protein Drugs
Table Bill of Materials (BOM) Price of Recombinant Protein Drugs
Table Labor Cost of Recombinant Protein Drugs
Table Depreciation Cost of Recombinant Protein Drugs
Table Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2015
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Table United States Price Analysis of Recombinant Protein Drugs 2011-2016 (USD/MT)
Table United States Cost Analysis of Recombinant Protein Drugs 2011-2016 (USD/MT)
Table United States Gross Analysis of Recombinant Protein Drugs 2011-2016
Table Capacity (K MT) and Commercial Production Date of United States Recombinant Protein Drugs Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Recombinant Protein Drugs Manufacturers in 2015
Table R&D Status and Technology Source of United States Recombinant Protein Drugs Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Recombinant Protein Drugs Key Manufacturers in 2015
Table United States Production of Recombinant Protein Drugs by Regions 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Regions in 2015
Table United States Production of Recombinant Protein Drugs by Types in 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Type in 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2015
Table United States Sales of Recombinant Protein Drugs by Applications 2011-2016 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Applications 2011-2016
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2014
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2015
Table Price Comparison of United States Recombinant Protein Drugs Key Manufacturers in 2015 (USD/MT)
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Recombinant Protein Drugs 2011-2016
Table United States Consumption Volume of Recombinant Protein Drugs by Regions 2011-2016 (K MT)
Table United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Consumption Volume Market Share of Recombinant Protein Drugs by Regions in 2015
Table United States Consumption Value of Recombinant Protein Drugs by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Recombinant Protein Drugs by Regions 2011-2016
Figure United States Consumption Value Market Share of Recombinant Protein Drugs by Regions in 2014
Figure United States Consumption Value Market Share of Recombinant Protein Drugs by Regions in 2015
Table Consumption Price of Recombinant Protein Drugs by Regions 2011-2016 (USD/MT)
Table United States and Major Manufacturers Capacity of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Capacity Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Production Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Recombinant Protein Drugs 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Recombinant Protein Drugs Manufacturers 2011-2016
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Recombinant Protein Drugs 2011-2016
Figure United States Capacity Utilization Rate of Recombinant Protein Drugs 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Recombinant Protein Drugs 2011-2016
Figure United States Production Market Share of Major Recombinant Protein Drugs Manufacturers in 2014
Figure United States Production Market Share of Major Recombinant Protein Drugs Manufacturers in 2015
Figure United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers in 2014
Figure United States Sales Market Share of Major Recombinant Protein Drugs Manufacturers in 2015
Figure United States Sales (K MT) and Growth Rate of Recombinant Protein Drugs 2011-2016
Table United States Supply, Consumption and Gap of Recombinant Protein Drugs 2011-2016 (K MT)
Table United States Import, Export and Consumption of Recombinant Protein Drugs 2011-2016 (K MT)
Table Price of United States Recombinant Protein Drugs Major Manufacturers 2011-2016 (USD/MT)
Table Gross Margin of United States Recombinant Protein Drugs Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Recombinant Protein Drugs 2011-2016 (M USD)
Table United States Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Recombinant Protein Drugs 2011-2016
Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Novo Nordisk
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Novo Nordisk 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Novo Nordisk 2011-2016
Table Novo Nordisk Recombinant Protein Drugs SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Amgen
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Amgen 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Amgen 2011-2016
Table Amgen Recombinant Protein Drugs SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Sanofi
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Sanofi 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Sanofi 2011-2016
Table Sanofi Recombinant Protein Drugs SWOT Analysis
Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Eli Lilly
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Eli Lilly 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Eli Lilly 2011-2016
Table Eli Lilly Recombinant Protein Drugs SWOT Analysis
Table Merck Serono Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Merck Serono
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Merck Serono 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Merck Serono 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Merck Serono 2011-2016
Table Merck Serono Recombinant Protein Drugs SWOT Analysis
Table Ortho Biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Ortho Biotech
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Ortho Biotech 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Ortho Biotech 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Ortho Biotech 2011-2016
Table Ortho Biotech Recombinant Protein Drugs SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Roche
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Roche 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Roche 2011-2016
Table Roche Recombinant Protein Drugs SWOT Analysis
Table Kyowa Hakko Kirin Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Kyowa Hakko Kirin
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Kyowa Hakko Kirin 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Kyowa Hakko Kirin 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Kyowa Hakko Kirin 2011-2016
Table Kyowa Hakko Kirin Recombinant Protein Drugs SWOT Analysis
Table Pharmingen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Pharmingen
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Pharmingen 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Pharmingen 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Pharmingen 2011-2016
Table Pharmingen Recombinant Protein Drugs SWOT Analysis
Table Abcam Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Abcam
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Abcam 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Abcam 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Abcam 2011-2016
Table Abcam Recombinant Protein Drugs SWOT Analysis
Table GenSci Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of GenSci
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of GenSci 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of GenSci 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of GenSci 2011-2016
Table GenSci Recombinant Protein Drugs SWOT Analysis
Table SL PHARM Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of SL PHARM
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of SL PHARM 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of SL PHARM 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of SL PHARM 2011-2016
Table SL PHARM Recombinant Protein Drugs SWOT Analysis
Table Dongbao Pharm Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Dongbao Pharm
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Dongbao Pharm 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Dongbao Pharm 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Dongbao Pharm 2011-2016
Table Dongbao Pharm Recombinant Protein Drugs SWOT Analysis
Table Ankebio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Ankebio
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Ankebio 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Ankebio 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Ankebio 2011-2016
Table Ankebio Recombinant Protein Drugs SWOT Analysis
Table NCPC Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of NCPC
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of NCPC 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of NCPC 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of NCPC 2011-2016
Table NCPC Recombinant Protein Drugs SWOT Analysis
Table Heng Rui Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Protein Drugs Picture and Specifications of Heng Rui
Table Recombinant Protein Drugs Capacity (K MT), Production (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Heng Rui 2011-2016
Figure Recombinant Protein Drugs Capacity (K MT), Production (K MT) and Growth Rate of Heng Rui 2011-2016
Figure Recombinant Protein Drugs Production (K MT) and United States Market Share of Heng Rui 2011-2016
Table Heng Rui Recombinant Protein Drugs SWOT Analysis
Table Recombinant Protein Drugs Price by Regions 2011-2016
Table Recombinant Protein Drugs Price by Product Types 2011-2016
Table Recombinant Protein Drugs Price by Companies 2011-2016
Table Recombinant Protein Drugs Gross Margin by Companies 2011-2016
Table Price Comparison of Recombinant Protein Drugs by Regions 2011-2016 (USD/MT)
Table Price of Different Recombinant Protein Drugs Product Types (USD/MT)
Table Market Share of Different Recombinant Protein Drugs Price Level
Table Gross Margin of Different Recombinant Protein Drugs Applications
Table Marketing Channels Status of Recombinant Protein Drugs
Table Traders or Distributors of Recombinant Protein Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Recombinant Protein Drugs (USD/MT) in 2015
Table United States Import, Export, and Trade of Recombinant Protein Drugs (K MT)
Figure United States Capacity (K MT), Production (K MT) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Capacity Utilization Rate of Recombinant Protein Drugs 2016-2021
Table United States Recombinant Protein Drugs Production by Type 2016-2021 (K MT)
Table United States Recombinant Protein Drugs Production Market Share by Type 2016-2021
Figure United States Production Market Share of Recombinant Protein Drugs by Type in 2021
Figure United States Sales (K MT) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Recombinant Protein Drugs 2016-2021
Figure United States Sales of Recombinant Protein Drugs by Applications 2016-2021 (K MT)
Table United States Production Market Share of Recombinant Protein Drugs by Applications 2016-2021
Figure United States Production Market Share of Recombinant Protein Drugs by Applications in 2021
Table United States Production, Import, Export and Consumption of Recombinant Protein Drugs 2016-2021 (K MT)
Table United States Production (K MT), Price (USD/MT), Cost (USD/MT), Revenue (M USD) and Gross Margin of Recombinant Protein Drugs 2016-2021
Table Major Raw Materials Suppliers of Recombinant Protein Drugs with Contact Information
Table Manufacturing Equipment Suppliers of Recombinant Protein Drugs with Contact Information
Table Major Players of Recombinant Protein Drugs with Contact Information
Table Key Consumers of Recombinant Protein Drugs with Contact Information
Table Supply Chain Relationship Analysis of Recombinant Protein Drugs
Table New Project SWOT Analysis of Recombinant Protein Drugs
Table New Project Investment Feasibility Analysis of Recombinant Protein Drugs
Table Part of Interviewees Record List
